EUVIMEDEUVIMED entdecken
Crossref

Cranial bone marrow–derived monocytes promote neuroinflammation in chronic traumatic brain injury

Zhichao Lu iD, Chenxing Wang iD, Peipei Gong iD, Qianqian Liu iD, Xingjia Zhu iD, Bin Yang iD, Xide Xu, Rui Jiang iD, Zhongzheng Jia, Chunfeng Sun iD, Yongqi Zhu, Yingcheng Wu iD und 5 weitere

Science Translational Medicine · 30.09.2026 · 18 (869)

DOI: 10.1126/scitranslmed.aef5898 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 30.09.2026. Verfasst von Zhichao Lu und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Na…. Hauptthemen laut MEDLINE: Brain Injuries, Traumatic, Monocytes, Neuroinflammatory Diseases, Skull. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Ministry of Science and Technology of the People´s Republic of China, Opening Foundation of State Key Laboratory of Neurology and Oncology Drug Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with chronic traumatic brain injury (cTBI) experience long-term exacerbated neurological decline, which is even more severe in older patients, yet the underlying mechanisms remain unclear. Cranial bone marrow (CBM) has recently been recognized as an adjacent immune surveillance organ of the brain that rapidly responds to acute brain injury. We investigated whether CBM-derived immune cells contribute to chronic neuroinflammation after cTBI by integrating clinical specimens, cell-tracing strategies, multiomics profiling, transgenic animal assays, adoptive cell transfer, and a proof-of-concept randomized clinical trial. We found that cTBI induced persistent aberrant myelopoiesis in the CBM, characterized by expansion of inflammatory monocytes/macrophages (Mo/Macs), which aggravated with aging. These CBM-derived Mo/Macs actively migrated into brain parenchyma, where they fueled chronic neuroinflammation and drove neurological deficits. Mechanistically, age-related peroxisome proliferator–activated receptor α (PPARα) deficiency caused lipid metabolism dysfunction in these Mo/Macs, enhancing H3K4me3-mediated regulation of inflammatory chromatin states and thereby promoting neuroinflammation. Activation of PPARα via fenofibrate rectified Mo/Mac lipid metabolism and reduced inflammatory Mo/Mac infiltration into the brain. In a proof-of-concept randomized clinical trial enrolling 40 older adult patients with cTBI, fenofibrate treatment reduced plasma neurofilament light chain levels and improved cognitive functions. Together, these findings demonstrate that CBM-originated inflammatory Mo/Macs may serve as key inflammatory drivers of cTBI and further show that fenofibrate represents a potential therapeutic strategy for cTBI treatment in older adults.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain Injuries, TraumaticMonocytesNeuroinflammatory DiseasesSkullInflammationBone Marrow CellsAnimalsHumansPPAR alphaChronic DiseaseMaleFemaleMacrophagesMice, Inbred C57BLAgingLipid Metabolism

Substanzen

PPAR alpha

Autor:innen und Institutionen

  • Department of Neurosurgery, Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, Jiangsu 226001, China.
  • Neuro-Microscopy and Minimally Invasive Translational Medicine Innovation Center, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, China.
  • State Key Laboratory of Neurology and Oncology Drug Development, Nanjing, Jiangsu 210042, China.
  • Renal Research Group, Cardiovascular Sciences, School of Medical Sciences, College of Life Sciences, University of Leicester, University Hospitals of Leicester, Leicester LE1 9HN, UK.
  • Department of Medical Imaging, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, Jiangsu 226001, China.
  • Department of Nuclear Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, Jiangsu 226001, China.

ORCID-Profile: Zhichao Lu, Chenxing Wang, Peipei Gong, Qianqian Liu, Xingjia Zhu, Bin Yang, Rui Jiang, Chunfeng Sun, Yingcheng Wu, Jingwei Zhao, Bin Wei, Kaibin Shi, Wei Shi

Förderung

  • National Natural Science Foundation of China
  • Ministry of Science and Technology of the People´s Republic of China
  • Opening Foundation of State Key Laboratory of Neurology and Oncology Drug Development
  • Neuro- Microscopy and Minimally Invasive Translational Medicine Innovation Center

Zitieren

APA

Lu, Z., Wang, C., Gong, P., Liu, Q., Zhu, X., Yang, B., Xu, X., Jiang, R., Jia, Z., Sun, C., Zhu, Y., Wu, Y., Zhao, J., Song, A., Wei, B., Shi, K., & Shi, W. (2026). Cranial bone marrow–derived monocytes promote neuroinflammation in chronic traumatic brain injury. Science Translational Medicine, 18(869). https://doi.org/10.1126/scitranslmed.aef5898

Vancouver

Lu Z, Wang C, Gong P, Liu Q, Zhu X, Yang B, et al. Cranial bone marrow–derived monocytes promote neuroinflammation in chronic traumatic brain injury. Science Translational Medicine. 2026;18(869). doi:10.1126/scitranslmed.aef5898

BibTeX
@article{Lu2026,
  author = {Lu, Zhichao and Wang, Chenxing and Gong, Peipei and Liu, Qianqian and Zhu, Xingjia and Yang, Bin and Xu, Xide and Jiang, Rui and Jia, Zhongzheng and Sun, Chunfeng and Zhu, Yongqi and Wu, Yingcheng and Zhao, Jingwei and Song, Anyi and Wei, Bin and Shi, Kaibin and Shi, Wei},
  title = {Cranial bone marrow–derived monocytes promote neuroinflammation in chronic traumatic brain injury},
  journal = {Science Translational Medicine},
  year = {2026},
  volume = {18},
  number = {869},
  doi = {10.1126/scitranslmed.aef5898}
}
Kostenlos starten →